Latest filing published 16 Apr 2026 for agilon health, inc., €7,511.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Girish Venkatachaliah in Agilon Health, Inc., where the filings describe the role as senior executive. The record holds 20 filings, for trades running from 14 April 2021 to 15 April 2026.
Purchases make up the whole of the open-market record (3 purchases). The totals exclude 3 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 17 share grants. So far in 2026, the count stands at 1 purchase and no sales.
The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The newest entry dates from 16 April 2026: a share grant of €1,845, in Agilon Health, Inc. The last insider purchase was made public on 11 March 2026, 227 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations